PET/CT早期检出继发性中枢神经系统淋巴瘤
本文报告一例60岁淋巴瘤患者,再分期PET/CT于左侧小脑半球见FDG高摄取灶,而同期MRI脑部未见对应异常,遂采取期待处理。6个月后该病灶代谢进展,MRI方显示为强化肿块,按淋巴瘤复发治疗后PET/CT示代谢缓解,提示PET/CT可在结构改变出现前检出代谢变化。
要点
- 60岁淋巴瘤患者再分期PET/CT见左侧小脑半球FDG高摄取灶,同期MRI脑部未见对应异常。
- 6个月后该FDG高摄取灶代谢进展,此时MRI方显示为强化肿块。
- 按推测的淋巴瘤复发治疗后PET/CT示代谢缓解。
核心结论
- 本病例说明PET/CT较解剖影像具有优势,可在结构改变变得明显之前检出代谢变化。
研究设计与样本
- 本文为病例报告,报告一例60岁淋巴瘤患者继发性中枢神经系统复发经PET/CT初始检出的经过。
主要发现
- 再分期PET/CT于左侧小脑半球见FDG高摄取灶,同期MRI脑部未见对应异常,随后采取期待处理。
- 6个月后该左侧小脑半球FDG高摄取灶代谢进展,此时MRI亦显示为强化肿块。
- 按推测的淋巴瘤复发治疗后PET/CT示代谢缓解。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We present a case of secondary central nervous system relapse of lymphoma detected initially on PET/CT without corresponding findings on MRI. A 60-year-old lymphoma patient demonstrated an FDG-avid focus in left cerebellar hemisphere on restaging PET/CT. MRI brain showed no corresponding abnormality, and expectant management ensued. Six months later, she represented with metabolic progression of previously seen FDG-avid focus in left cerebellar hemisphere, now also manifesting as an enhancing mass on MRI. Posttreatment scan for presumed lymphoma relapse showed metabolic response. This case demonstrates the advantage of PET/CT over anatomical imaging to detect metabolic changes before structural changes become apparent.
引用
- Appaduray SP, Khoo J, Somasundaram N, et al. Early Detection of Secondary Central Nervous System Lymphoma on PET/CT. Clin Nucl Med. 2020. PMID: 32149796. doi:10.1097/RLU.0000000000002991
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。